TheraBiol Inc (TBI) is a biopharmaceutical company founded in May 2012 by a core group of scientists, physicians and entrepreneurs with the support of the QB3 Incubator Program (www.qb3.org) at UCSF. The principal objective at TheraBiol is to develop safe and effective antibodies for the prevention, treatment, and cure of human immunodeficiency virus 1 (HIV-1) infection.

TheraBiol, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.therabiol.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address185 Berry Street (Lobby 6), CA 94107San FranciscoUnited States
185 Berry Street (Lobby 6), CA 94107
San Francisco
United States
Contact Number+1 415-600-1693
+1 415-600-1693
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/therabiol-inc.” connections=”true” suffix=””]